ArticleJournal of advanced research2026
scMapNet: Marker-based cell type annotation of scRNA-seq data via vision transfer learning with tabular-to-image transformations.
Article in Journal of advanced research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Post-translational modifications in hepatocellular carcinoma: mechanisms and therapeutic potential.Medical oncology (Northwood, London, England) · 2025Review
- Targeting autophagy to enhance cancer immunotherapy: emerging mechanisms and strategies.Medical oncology (Northwood, London, England) · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionIdentifying cell types is a key step in single-cell RNA sequencing data analysis that aids in understanding cellular heterogeneity and facilitates downstream analyses such as those concerning cell-cell interactions and data integration. Cell-type annotation methods often rely on unsupervised clustering algorithms, followed by manual or automatic annotation via marker genes, which are prone to inefficiency and inconsistency. Supervised methods, while more automated and consistent, have gained remarkable attention because of the rapid growth of large-scale, high-quality single-cell datasets. However, these methods cannot effectively leverage cellular marker knowledge and much unlabelled data.
objectivesThis study aims to introduce a novel deep learning method, scMapNet, which can sufficiently learn cellular marker knowledge and information from unlabelled data.
methodsscMapNet is a self-supervised deep learning model based on masked autoencoders (MAE) and vision transformer (ViT), which adopts treemap transformations to leverage cell marker information and capture information by pretraining on large amounts of unlabelled data.
resultsscMapNet outperforms six competing methods across diverse datasets, excelling in accuracy and batch insensitivity. Moreover, scMapNet can effectively extract attention gene information, providing strong support for cell type identification. The models and codes are available at https://github.com/Yuz7/scMapNet.
conclusionscMapNet shows significant performance in annotation accuracy and batch insensitivity. Besides, this method also has good interpretability and can provide biological insights for researchers.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.